Details for New Drug Application (NDA): 019921
✉ Email this page to a colleague
NDA 019921 describes OCUFLOX, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the OCUFLOX profile page.
The generic ingredient in OCUFLOX is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
The generic ingredient in OCUFLOX is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
Suppliers and Packaging for NDA: 019921
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OCUFLOX | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 019921 | NDA | Allergan, Inc. | 11980-779 | 11980-779-05 | 1 BOTTLE, DROPPER in 1 CARTON (11980-779-05) / 5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.3% | ||||
| Approval Date: | Jul 30, 1993 | TE: | AT | RLD: | Yes | ||||
Complete Access Available with Subscription
